1109 related articles for article (PubMed ID: 19505660)
1. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
Pohl D; Tutuian R
Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
[TBL] [Abstract][Full Text] [Related]
2. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
Hirano I
Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
[TBL] [Abstract][Full Text] [Related]
3. Laboratory based investigations for diagnosing gastroesophageal reflux disease.
Dolder M; Tutuian R
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):787-98. PubMed ID: 21126694
[TBL] [Abstract][Full Text] [Related]
4. Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review.
Zentilin P; Dulbecco P; Savarino E; Giannini E; Savarino V
Dig Liver Dis; 2004 Sep; 36(9):565-9. PubMed ID: 15460839
[TBL] [Abstract][Full Text] [Related]
5. Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance.
Tutuian R; Castell DO
Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():27-37. PubMed ID: 16939430
[TBL] [Abstract][Full Text] [Related]
6. Review article: The measurement of non-acid gastro-oesophageal reflux.
Smout AJ
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():7-12. PubMed ID: 18081643
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
[TBL] [Abstract][Full Text] [Related]
8. Impedance-pH monitoring: new standard for measuring gastro-oesophageal reflux.
Bredenoord AJ
Neurogastroenterol Motil; 2008 May; 20(5):434-9. PubMed ID: 18416700
[TBL] [Abstract][Full Text] [Related]
9. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
10. Relationship between gastro-oesophageal reflux and gastric activity in newborns assessed by combined intraluminal impedance, pH metry and epigastric impedance.
Cresi F; de Sanctis L; Savino F; Bretto R; Testa A; Silvestro L
Neurogastroenterol Motil; 2006 May; 18(5):361-8. PubMed ID: 16629863
[TBL] [Abstract][Full Text] [Related]
11. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
[TBL] [Abstract][Full Text] [Related]
12. Current applications of evolving methodologies in gastroesophageal reflux disease testing.
Weber C; Davis CS; Fisichella PM
Dig Liver Dis; 2011 May; 43(5):353-7. PubMed ID: 21324762
[TBL] [Abstract][Full Text] [Related]
13. Review: what do we mean by GERD?--definition and diagnosis.
Jones R; Galmiche JP
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():2-10. PubMed ID: 16042654
[TBL] [Abstract][Full Text] [Related]
14. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
Vela MF
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):665-72. PubMed ID: 19072344
[TBL] [Abstract][Full Text] [Related]
15. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance.
Hong SK; Vaezi MF
Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):1-22, v. PubMed ID: 19232277
[TBL] [Abstract][Full Text] [Related]
16. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
[TBL] [Abstract][Full Text] [Related]
17. New developments in detection of gastroesophageal reflux.
Emerenziani S; Sifrim D
Curr Opin Gastroenterol; 2005 Jul; 21(4):450-3. PubMed ID: 15930987
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic difficulties during combined multichannel intraluminal impedance and pH monitoring in patients with esophagitis or Barrett's esophagus.
Waśko-Czopnik D; Błoński W; Paradowski L
Adv Med Sci; 2007; 52():196-8. PubMed ID: 18217418
[TBL] [Abstract][Full Text] [Related]
19. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
[TBL] [Abstract][Full Text] [Related]
20. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
